HIV treatment innovation leads to better lifetime choices, study finds
Domestic violence and illicit drug use plummeted among women who realized they could live decades longer than they’d expected because of a new HIV treatment, according to a new study involving a Washington University in St. Louis health care-innovation researcher.
Chemist Barnes receives teacher-scholar award
Alexander Barnes, assistant professor of chemistry in Arts & Sciences at Washington University in St. Louis, has been recognized with a 2018 Camille Dreyfus Teacher-Scholar Award, recognizing his independent scholarship and deep commitment to education.
Project ARK to provide HIV testing, area for youth at PrideFest
Project ARK , a Washington University School of Medicine program that provides health-care and support services for children and teens with HIV, will host an area designated for youth at St. Louis’ annual PrideFest, a three-day event downtown that begins Friday. Among activities at the site will be free HIV testing for anyone 25 or younger.
Diabetes drug may reduce heart attack risk in HIV patients
A diabetes drug may have benefits beyond lower blood sugar in patients with HIV. New research from the laboratory of Kevin E. Yarasheski, PhD, suggests the drug may prevent cardiovascular problems because it works to reduce inflammation that is linked to heart disease and stroke in these patients. The drug both improved metabolism and reduced inflammation in HIV-positive adults on antiretroviral therapy.
Trial to study whether statins reduce strokes, heart attacks in HIV patients
The Washington University AIDS Clinical Trials Unit is the first in the nation to open a clinical trial evaluating whether statins reduce heart attacks and strokes in patients with human immunodeficiency virus (HIV).
Hepatitis C ruled out as cause of mental impairment in HIV patients
Secondary infection with hepatitis C does not cause the memory loss, personality changes and other mental impairments seen in patients with long-term HIV infections, a new study shows. Pictured is first author David Clifford, MD, of the School of Medicine.
Washington People: Beau Ances
Beau Ances, MD, PhD, is using the latest brain scanning techniques to better understand how long-term HIV infection impairs memory and other mental functions. He’s also applying his expertise in neuroimaging to Alzheimer’s disease and other degenerative disorders.
Molecular scissors help viruses break out of cells
Scientists at the School of Medicine have produced the first detailed images of a protein important to viral infection. The images, from Phyllis Hanson, MD, PhD, and her colleagues, are of molecular scissors that let viruses such as HIV bud from infected cells.
Youth group to host HIV awareness event April 10
In recognition of National Youth HIV & AIDS Awareness Day, a youth leadership program of Project ARK and The SPOT will host an open-mic event to encourage young people to talk about HIV/AIDS and sexual health. The Youth Advocacy Committee will host the event from 7-9 p.m. Thursday, April 10, at Blank Space, 2847 Cherokee St., St. Louis.
$4.9 million grant to fund AIDS research
The AIDS Clinical Trials Site at the School of Medicine has been awarded a National Institutes of Health grant that supports testing of treatments for HIV, AIDS and the many complications they cause. Pictured is the principal investigator, David Clifford, MD.
View More Stories